These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21206387)

  • 1. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?
    Wei S; Asamura H; Kawachi R; Sakurai H; Watanabe S
    J Thorac Oncol; 2011 Feb; 6(2):310-8. PubMed ID: 21206387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
    Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
    Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
    Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Proposal for Combination of Lymph Node Ratio and Anatomic Location of Involved Lymph Nodes for Nodal Classification in Non-Small Cell Lung Cancer.
    Ding X; Hui Z; Dai H; Fan C; Men Y; Ji W; Liang J; Lv J; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; Lu N; He J; Wang L
    J Thorac Oncol; 2016 Sep; 11(9):1565-73. PubMed ID: 27223457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of the Currently Used Nodal Stage Classification with the Number of Metastatic Lymph Nodes and the Number of Metastatic Lymph Node Stations for Non-Small Cell Lung Cancer; Which of These Is the Best Prognostic Factor?
    Citak N; Aksoy Y; Isgörücü Ö; Obuz C; Acikmese B; Buyukkale S; Metin M; Sayar A
    Zentralbl Chir; 2020 Dec; 145(6):565-573. PubMed ID: 31648357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
    Fukui T; Mori S; Yokoi K; Mitsudomi T
    J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes.
    Liu H; Yan T; Zhang T; Chen X; Wang Y; Du J
    Medicine (Baltimore); 2019 May; 98(20):e15645. PubMed ID: 31096486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
    Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of International Association for the Study Of Lung Cancer proposals for the revision of N descriptors in lung cancer.
    Lee JG; Lee CY; Bae MK; Park IK; Kim DJ; Kim KD; Chung KY
    J Thorac Oncol; 2008 Dec; 3(12):1421-6. PubMed ID: 19057267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems.
    Pepek JM; Chino JP; Marks LB; D'amico TA; Yoo DS; Onaitis MW; Ready NE; Hubbs JL; Boyd J; Kelsey CR
    J Thorac Oncol; 2011 Apr; 6(4):757-61. PubMed ID: 21325975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
    Maeshima AM; Tsuta K; Asamura H; Tsuda H
    Cancer; 2012 Sep; 118(18):4512-8. PubMed ID: 22282325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis to subsegmental and segmental lymph nodes in patients resected for non-small cell lung cancer: prognostic impact.
    Rena O; Boldorini R; Papalia E; Turello D; Massera F; Davoli F; Roncon A; Baietto G; Casadio C
    Ann Thorac Surg; 2014 Mar; 97(3):987-92. PubMed ID: 24480258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a thoracic surgeon identify lymph node metastases during surgery based on their size? Analysis of 844 metastatic and 10,462 nonmetastatic lymph nodes.
    Suemitsu R; Takeo S; Matsuzawa H; Yamaguchi M; Momosaki S; Uesugi N
    J Thorac Oncol; 2010 Mar; 5(3):349-53. PubMed ID: 20009772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which N Descriptor Is More Predictive of Prognosis in Resected Non-small Cell Lung Cancer: The Number of Involved Nodal Stations or the Location-Based Pathological N Stage?
    Xu L; Su H; She Y; Dai C; Zhao M; Gao J; Xie H; Ren Y; Xie D; Chen C
    Chest; 2021 Jun; 159(6):2458-2469. PubMed ID: 33352193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative prognosis in patients with non-small cell lung cancer with synchronous ipsilateral intrapulmonary metastasis.
    Yoshino I; Nakanishi R; Osaki T; Hasuda S; Taga S; Takenoyama M; Yoshimatsu T; Yasumoto K
    Ann Thorac Surg; 1997 Sep; 64(3):809-13. PubMed ID: 9307478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
    Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
    Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
    Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.